Regencell Bioscience Holdings Ltd
RGC · Medicinal Chemicals and Botanical Products
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Lo William Wing Yan Dr: Form 4
Insider disclosure · Filed · Report period 27 May 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001829667 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RGC on Nasdaq
- SEC industry group
- Medicinal Chemicals and Botanical Products (Office of Life Sciences)
- Business address
- 9/F Chinachem Leighton Plaza, 29 Leighton Road, Causeway Bay, Hong Kong
- Incorporated in
- Cayman Islands
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields